Jarin-1

CAS No. 1212704-51-2

Jarin-1( —— )

Catalog No. M33388 CAS No. 1212704-51-2

Jarin-1, a jasmonic acid-amido synthetase (JAR1) inhibitor (IC50: 3.8 μM), specifically suppresses bioactive JA biosynthesis in Arabidopsis and other plants.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 202 In Stock
5MG 187 In Stock
10MG 312 In Stock
25MG 530 In Stock
50MG 733 In Stock
100MG 1042 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Jarin-1
  • Note
    Research use only, not for human use.
  • Brief Description
    Jarin-1, a jasmonic acid-amido synthetase (JAR1) inhibitor (IC50: 3.8 μM), specifically suppresses bioactive JA biosynthesis in Arabidopsis and other plants.
  • Description
    Jarin-1 is a jasmonic acid-amido synthetase (JAR1) inhibitor with an IC50 of 3.8 μM. Jarin-1 specific inhibits bioactive JA (jasmonoyl-isoleucine, JA-Ile) biosynthesis in Arabidopsis and other plants.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1212704-51-2
  • Formula Weight
    471.55
  • Molecular Formula
    C28H29N3O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 33.33 mg/mL (70.68 mM; Ultrasonic )
  • SMILES
    [H][C@@]12CN(C[C@@]([H])(C1)c1ccc(NC(=O)c3ccc(cc3)-c3ccccc3)c(=O)n1C2)C(=O)CCOC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Delgado LD, et al. Application of a JA-Ile Biosynthesis Inhibitor to Methyl Jasmonate-Treated Strawberry Fruit Induces Upregulation of Specific MBW Complex-Related Genes and Accumulation of Proanthocyanidins. Molecules. 2018 Jun 13;23(6). pii: E1433.?
molnova catalog
related products
  • 3-Oxo-alpha-ilexanol...

    3-Oxo-alpha-ilexanolic acid

  • Litifilimab

    Litifilimab, a humanized IgG1-κ antibody, targets the C-type lectin domain family 4 member C (CLEC4C) and has potential applications in the study of cutaneous lupus erythematosus (CLE) .

  • Retronecine

    Retronecine acts as the better competitor for the competitive inhibition of antibodies to Retronecine.